scholarly journals Secondary pulmonary malignancies requiring interventional bronchoscopic procedures

2021 ◽  
Vol 29 (3) ◽  
pp. 360-369
Author(s):  
Efsun Gonca Uğur Chousein ◽  
Demet Turan ◽  
Mehmet Akif Özgül ◽  
Erdoğan Çetinkaya
Keyword(s):  
Airway Obstruction ◽  
Clinical Characteristics ◽  
Argon Plasma Coagulation ◽  
Survival Rates ◽  
Argon Plasma ◽  
Shortness Of Breath ◽  
Airway Patency ◽  
Plasma Coagulation ◽  
Life Threatening ◽  
The Mean

Background: In this study, we aimed to share our singlecenter experience and to investigate the effect of interventional bronchoscopic procedures on secondary pulmonary malignancies in terms of complications, success, and survival rates. Methods: A total of 83 patients (42 males, 41 females; mean age: 57.8±15.2 years; range, 18 to 94 years) with secondary pulmonary malignancies who underwent interventional bronchoscopic procedures between January 2009 and December 2019 were retrospectively reviewed. Data including demographic and clinical characteristics of the patients, complications, and success and survival rates were recorded. Results: The most common secondary pulmonary malignancies were kidney and thyroid tumors with the complaints of cough, shortness of breath, and hemoptysis. The mean duration before the diagnosis was 34.7±52.8 (range, 0.1 to 219.3) months, and the mean survival after the diagnosis were 10±13.1 (range, 0.2 to 44.4) months. A total of 92% of the patients had an airway obstruction of >50% and the interventional bronchoscopic procedures such as argon plasma coagulation, laser, cryo, and mechanical resection were successful in achieving airway patency. Laser application was found to significantly improve survival (p=0.015). Acute complication rate was 8.4% and mortality rate was 0%. Conclusion: In patients with tracheobronchial lesions due to secondary pulmonary malignancies, interventional bronchoscopic procedures, regardless of the stage of the disease, provide rapid palliation in life-threatening symptoms such as dyspnea and hemoptysis due to airway obstruction, prolonging patient"s survival and gain time for additional treatments to take effect for primary disease.

Case of Life-Threatening Gas Embolism Associated With Argon Plasma Coagulation

CHEST Journal ◽  
2010 ◽  
Vol 138 (4) ◽  
pp. 116A
Author(s):  
Samaan Rafeq ◽  
Sugantha Sundar ◽  
Armin Ernst ◽  
Adnan Majid
Keyword(s):  
Argon Plasma Coagulation ◽  
Argon Plasma ◽  
Gas Embolism ◽  
Plasma Coagulation ◽  
Life Threatening

Treatment of recurrent respiratory papillomatosis with argon plasma coagulation

1997 ◽  
Vol 111 (4) ◽  
pp. 381-384 ◽  
Author(s):  
W. Bergler ◽  
M. Hönig ◽  
K. Götte ◽  
G. Petroianu ◽  
K. Hörmann
Keyword(s):  
Argon Plasma Coagulation ◽  
Argon Plasma ◽  
Good Control ◽  
Flexible Endoscopy ◽  
Recurrent Respiratory Papillomatosis ◽  
Lower Airway ◽  
Plasma Coagulation ◽  
Difficult Condition ◽  
Life Threatening ◽  
First Time

AbstractExtension of recurrent respiratory papillomatosis (RRP) to the lower airway in children is life-threatening and an extremely difficult condition to treat. We present the case of a seven-year-old girl with progressive RRP since the age of two. Repeated CO2 laser treatment and interferon-alpha treatment could not prevent tracheotomy and spread to the trachea. We used argon plasma coagulation (APC) with flexible endoscopy for the first time for the treatment of RRP. APC gives a controlled limited penetration into the tissue and good control of bleeding. There is no carbonization or vaporization which makes it a suitable method for the treatment of lower airway RRP. After a few treatments with APC, we gained very good control of the disease with no side-effects or complications. The described application of APC seems to be a promising way to treat lower airway RRP.

Endobronchial Argon Plasma Coagulation for Treatment of Hemoptysis and Neoplastic Airway Obstruction

CHEST Journal ◽  
2001 ◽  
Vol 119 (3) ◽  
pp. 781-787 ◽  
Author(s):  
Rodolfo C. Morice ◽  
Turhan Ece ◽  
Ferah Ece ◽  
Leendert Keus
Keyword(s):  
Airway Obstruction ◽  
Argon Plasma Coagulation ◽  
Argon Plasma ◽  
Plasma Coagulation

scholarly journals Efficacy of Argon Plasma Coagulation Compared with Topical Formalin Application for Chronic Radiation Proctopathy

2008 ◽  
Vol 22 (2) ◽  
pp. 129-132 ◽  
Author(s):  
AA Alfadhli ◽  
WM Alazmi ◽  
T Ponich ◽  
JM Howard ◽  
I Prokopiw ◽  
...  
Keyword(s):  
Argon Plasma Coagulation ◽  
Argon Plasma ◽  
Hemoglobin Level ◽  
Treatment Modalities ◽  
Single Session ◽  
Rectal Pain ◽  
Female Ratio ◽  
Plasma Coagulation ◽  
Chronic Radiation ◽  
The Mean

BACKGROUND: Chronic radiation proctopathy (CRP) is a troublesome complication of radiotherapy to the pelvis for which current treatment modalities are suboptimal. Currently, the application of formalin to the rectal mucosa (AFR) and thermal ablation with argon plasma coagulation (APC) are the most promising options.OBJECTIVE: To compare the efficacy and safety of AFR with APC for CRP.PATIENTS AND METHODS: Records of 22 patients (male to female ratio, 19:3; mean age, 74 years) who received either APC or AFR for chronic hematochezia caused by CRP, and who were evaluated and treated between May 1998 and April 2002, were reviewed. Complete evaluations were made three months after completion of each therapeutic modality. Patients were considered to be responders if there was a 10% increase in hemoglobin from baseline or complete normalization of hemoglobin (male patients, higher than 130 g/L; female patients, higher than 115 g/L) without the requirement for blood transfusion.RESULTS: The mean hemoglobin level before therapy was 107 g/L. Patients received an average of 1.78 sessions for APC and 1.81 sessions for AFR. Eleven patients (50%) were treated with APC alone, eight patients (36%) with AFR alone and three (14%) with both modalities (two with AFR followed by APC, and one with APC followed by AFR). Eleven of 14 patients (79%) in the APC group were responders, compared with three of 11 patients (27%) in the AFR group (P=0.017). In the APC group, seven of 11 responders required only a single session, while in the AFR group, only one patient responded after a single session. Adverse events (nausea, vomiting, flushing, abdominal cramps, rectal pain and fever) occurred in two patients after APC and in nine patients after AFR (P=0.001). In the APC group, the mean hemoglobin level increase was 20 g/L at three months follow-up, compared with 14 g/L in the AFR group.CONCLUSION: This retrospective study suggests that APC is more effective and safe than topical AFR to control hematochezia caused by CRP. Further studies are needed to confirm this observation.

Sign in / Sign up

Export Citation Format

Share Document